Definitive Contract 75D30126C21502
Award Date 9/15/26
Potential Completion Date 9/14/28
Potential Value $620K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30318, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $434,972 firm fixed price definitive contract to Micron Biomedical Inc. for the manufacturing of a dissolving microneedle patch. As a for-profit organization, Micron Biomedical Inc. will deliver the requested dissolving microneedle patch from its place of performance in Atlanta, GA by the completion date of September 30th, 2022. No set-aside designation was used for this award to support...
- The Centers for Disease Control and Prevention (CDC) awarded a $249,999 firm-fixed-price purchase order to Micron Biomedical Inc. for the delivery of microneedle patches. The award was made by the CDC's Pittsburgh office, and the work will be performed in Atlanta, Georgia. Micron Biomedical Inc. is a for-profit organization that specializes in the manufacturing and delivery of microneedle and bioneedle products for medical applications. This award appears to be part of the CDC's efforts to...
- <p>The CDC Pittsburgh office awarded a purchase order to Micron Biomedical Inc. for microneedle patch procurement on September 1, 2024, with a ceiling value of $249,999.00 and firm fixed price terms. Place of performance is Atlanta, Georgia. The order is scheduled for ultimate completion on August 31, 2026. No set-aside applies.</p>
- <p>The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Micron Biomedical Inc., a for-profit organization, for the research and development of a microneedle patch. The contract, which does not have a set-aside designation, has a potential value of $149,810.00 and a completion date of March 30, 2019. The place of performance is Atlanta, GA 30332, USA.</p>
- <p>The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $249,998.00 firm fixed-price purchase order to Micron Biomedical Inc., a for-profit organization, for the delivery of MICRON BIONEEDLE products. The contract has an August 30, 2019 completion date and was awarded on August 20, 2019. The place of performance is Atlanta, Georgia. No set-aside designation is mentioned.</p>
- <p>CDC Pittsburgh awarded a purchase order to Southern Research Institute for $399,999 on September 15, 2026, to assess the safety of a microneedle patch for rotavirus vaccination when administered intradermally in four doses in rats under Executive Order 14398. Work is performed in Birmingham, Alabama, with completion targeted for September 14, 2027. This is a firm fixed price, commercial item acquisition with no set-aside.</p>
- This definitive contract award of $749,000 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response is for Vaxess Technologies Inc. to deliver its MIMIX-COVID pre-fusion spike protein vaccine patch at scale. The prime contractor will manufacture up to 100 million shelf-stable, self-applied single-dose vaccine patches in response to Special Instructions 019 under the Easy Broad Agency Announcement BAA-20-100-SOL-0002. This solicitation...
- The Office of the Assistant Secretary for Preparedness and Response awarded a $741,426.80 firm fixed-price definitive contract to Georgia TECH Research Corp on July 10, 2024, to develop a user-friendly, point-of-care microneedle patch that rapidly collects dermal interstitial fluid from skin and employs multiplexed biosensors for simultaneous measurement of biomarkers. Place of performance is Atlanta, GA. The contract ceiling value is $741,426.80 with an ultimate completion date of October 8,...
- <p>The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a purchase order to The Ohio State University for $248,005 on September 6, 2024, to support testing of parenterally administered live attenuated rotavirus. Work is performed in Atlanta, Georgia. The order is firm fixed price with an ultimate completion date of September 5, 2026. No set-aside was used.</p>
- The Centers for Disease Control and Prevention awarded a definitive contract to University of North Carolina at Chapel Hill for dual implants for HIV treatment and prevention on August 15, 2023, with a ceiling value of $457,586 and an ultimate completion date of August 14, 2026, under a sole-source justification. The originating pre-solicitation, posted February 9, 2023, identified UNC/NCSU Joint Department of Biomedical Engineering as the sole capable source for design and manufacture of...